Appili Therapeutics is an infectious disease biopharmaceutical company that is purposefully built, portfolio-driven, and people-focused to fulfill its mission of solving life-threatening infections. By systematically identifying urgent infections with unmet needs, Appiliās goal is to strategically develop a pipeline of novel therapies to prevent deaths and improve lives.
View Top Employees from Appili TherapeuticsWebsite | http://www.appilitherapeutics.com/ |
Ticker | APLIF |
Revenue | $17 million |
Employees | 17 (10 on RocketReach) |
Founded | 2015 |
Address | #21-1344 Summer St, Halifax, Nova Scotia B3H 0A8, CA |
Phone | (902) 442-4655 |
Technologies |
JavaScript,
HTML,
Twitter
+15 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Health Care, Marketing, Sales and Marketing, Therapeutics |
Competitors | Destiny Pharma plc, Lakewood-Amedex Inc., Microbiotix, Inc, NewBiotics, Ruthigen, Inc. |
SIC | SIC Code 873 Companies, SIC Code 283 Companies, SIC Code 28 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 541 Companies |
Looking for a particular Appili Therapeutics employee's phone or email?
The Appili Therapeutics annual revenue was $17 million in 2024.
Gary Nabors is the Chief Development Officer of Appili Therapeutics.
10 people are employed at Appili Therapeutics.
Appili Therapeutics is based in Halifax, Nova Scotia.
The NAICS codes for Appili Therapeutics are [54, 325, 3254, 32, 32541, 541].
The SIC codes for Appili Therapeutics are [873, 283, 28, 87].